Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Ward

Personal Genome Diagnostics has appointed Douglas Ward as CEO and a member of the board of directors. Ward joins PGDx from Roche, where he most recently served as VP of companion diagnostics for Ventana Medical Systems, a Roche subsidiary. Prior to his work at Roche, he served as president and general manager of commercial operations for GE Healthcare's Life Sciences business in the Americas. Before that, he held positions of increasing responsibility at Bayer Healthcare, including country head for UK and Ireland, and VP of marketing and scientific affairs for Bayer Molecular Diagnostics.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.